Abstracts Publications
Early stages
-
T082: Radiation-free initial treatment of early-stage favorable classic Hodgkin Lymphoma (RAFTING) trial: three-year follow-up
Abstract Talk in Early Stages (Saturday 13:15–14:45)
View full abstract at Hemasphere…
- Andrea Gallamini
- Kateryna Filonenko
- Marco Picardi
- Stephane Chauvie
- Andrea Riccardo Filippi
- Maria Cristina Pirosa
- Luca Guerra
- Federico Fallanca
- Marta Bednarek
- Michał Kurlapski
- Eva Domingo-Doménech
- Andrea Visentin
- Caterina Patti
- Ramón Garcia Sanz
- Javier Nunez
- Javier Lopez
- Agnieszka Giza
- Adam Wyszomirski
- Alessandro Rambaldi
- Davide Rossi
- Anna Sureda
- Jan Maciej Zaucha
-
T083: Integrating E-HIPI and Interim PET to Refine Risk Stratification in Early-Stage Classic Hodgkin Lymphoma
Abstract Talk in Early Stages (Saturday 13:15–14:45)
View full abstract at Hemasphere…
- Alessandro Cellini
- Martina De Ferrari
- Giovanni Manfredi Assanto
- Alessandra Romano
- Gabriella Santuccio
- Candida Vitale
- Maria Chiara Montalbano
- Francesco Angotzi
- Andrea Serafin
- Nicolo' Danesin
- Arianna Bevilacqua
- Mattia D'Antiga
- Giovanni Leone
- Marta Coscia
- Francesco Di Raimondo
- Ilaria Del Giudice
- Francesco Piazza
- Livio Trentin
- Andrea Visentin
-
P084: Role of consolidative radiotherapy in preventing relapses and subsequently salvage ASCT in early-stage classic Hodgkin lymphoma
View full abstract at Hemasphere…
- Reyad Dada
- John Apostolidis
- Refaei Belal Ibrahim
- Asma Ahmed Salem
- Mostafa Ibrahim Mahmoud
- Hafiz Asif Iqbal
- Tarik Boubakra
- Hamza Ghatasheh
- Khalid Halahleh
-
P085: Definition of a risk collective for high cardiac radiation doses - A post-hoc analysis of the HD17 study by the German Hodgkin Study Group reference radiation oncology panel
View full abstract at Hemasphere…
- Michael Oertel
- Christopher Kittel
- David Rene Steike
- Michael Fuchs
- Christian Baues
- Dirk Vordermark
- Rita Engenhart-Cabilic
- Klaus Herfarth
- Heinz Schmidberger
- Peter Lukas
- Peter Borchmann
- Hans Theodor Eich
-
P086: TRIAL IN PROGRESS: PRIORITY (PET guided dose Reduction for InvOlved site Radiotherapy In early sTage unfavourable Hodgkin lymphoma: a randomized, phase III, non-inferiority study)
View full abstract at Hemasphere…
- Umberto Ricardi
- Fabio Matrone
- Barbara Botto
- Mario Levis
- Patrizia Ciammella
- Andrea Evangelista
- Ilenia Iamundo De Cumis
- Stephane Chauvie
- Francesca Ricci
- Piero Maria Stefani
- Luigi Rigacci
-
P087: AHOD2131: A Randomized Phase 3 Response-Adapted Trial Comparing Standard Therapy with Immuno-oncology Therapy for Children & Adults with Newly Diagnosed Stage I & II Classic Hodgkin Lymphoma
View full abstract at Hemasphere…
- Jennifer Seelisch
- Boyu Hu
- Lindsay A. Renfro
- Adam DuVall
- Yue Wu
- Steve Yoon-Ho Cho
- Bradford Scott Hoppe
- Sarah Milgrom
- Raymond Mailhot Vega
- Andrea C Lo
- David Hodgson
- Lisa Guilino Roth
- Natalie Grover
- Ann Steward LaCasce
- Justine M Kahn
- Susan Parsons
- Pamela Sue Hinds
- Pamela Blair Allen
- Andrew M. Evens
- Heiko Schoder
- Sharon M Castellino
- Kara M. Kelly
-
P088: Individualizing Consolidative Radiotherapy in Intermediate-Stage Hodgkin Lymphoma: A PET-Residual Re-Planning Analysis of Patients from the GHSG HD17 Trial
View full abstract at Hemasphere…
- David Rene Steike
- Michael Oertel
- Patrick Hölken
- Sebastian Lohmann
- Nick Schulze
- Johannes Rosenbrock
- Michael Fuchs
- Dirk Vordermark
- Rita Engenhart-Cabilic
- Klaus Herfarth
- Heinz Schmidberger
- Peter Lukas
- Christian Baues
- Bouthaina Dabaja
- Peter Borchmann
- Hans Theodor Eich
-
P089: Real-world implementation of a modified PET-adapted HD17 approach in early-stage Hodgkin lymphoma: a single-centre audit
View full abstract at Hemasphere…
- Athanasia Sinti Papadaki
- Rory Morrice
- Kirit Ardeshna
- Kate Cwynarski
- Satyen Gohil
- Irfan Kayani
- Suganya Sivabalasingham
- Jonathan Lambert
- Christopher McNamara
- Sajir Mohamedbhai
- Michael Northend
- Hassan Al-Sader
- Asma Batool
- Ingo Ringshausen
- Ali Rismani
- Andres Virchis
- William Townsend
- Maria Marzolini
-
P090: Omission of Radiotherapy is Associated with Inferior Progression-Free Survival in Bulky and Interim-PET-Positive Early-Stage Hodgkin Lymphoma: A Propensity-Matched Multicenter Real-World Analysis
View full abstract at Hemasphere…
- Alexandra Dreyfuss
- Nikita Dave
- Alison Moskowitz
- Joachim Yahalom
- Maria Alfaro
- Nicole Birrer
- Boyu Hu
- Rachel Koch
- Zachary Frosch
- Meryl Colton
- Carrie Ho
- Behzad Amoozgar
- Tatyana Feldman
- Abhiraj Saxena
- Joanna Rhodes
- Ashley Dunton
- Nirav Shah
- Amelia Mantione
- Harper Hubbeling
- Michael LaRiviere
- John Plastaras
- Beatrice Desai
- Brandon Imber
- Reid Muenzen
- Stefan Barta
- Jordan Carter
- Elise Chong
- Michael Cook
- Daniel Landsburg
- Sunita Nasta
- Stephen Schuster
- Colin Thomas
- Emily Tomasulo
- Jakub Svoboda
-
P091: Characteristic of patients with a positive end of treatment PET or experiencing early relapse despite interim PET negativity: analysis from the EORTC-LYSA-FIL H10 trial.
View full abstract at Hemasphere…
- Luigi Rigacci
- Wouter Plattel
- Marc Andrè
- Luigi Marcheselli
- Berthe Aleman
- Umberto Ricardi
- Caterina Christinelli
- Manuel Gotti
- Alessandro Re
- Martin Hutchings
- Véronique Edeline
- Monica Bellei
- Francesco Merli
- Aspasia Stamatoulas
- Sanne Tonino
- Vincent Ribrag
- Barbara Botto
- Massimo Federico
Children and adolescents
-
T071: The Genomic Landscape of Pediatric High-Risk Hodgkin Lymphoma: A Liquid Biopsy Study of COG AHOD1331
Abstract Talk in HL in Children and Adolescents (Sunday 08:00–09:15)
View full abstract at Hemasphere…
- Shuyu Shi
- Lianna J. Marks
- Hrishikesh K. Srinagesh
- Lena Osswald
- Stefan K. Alig
- Ragini Adams
- Maya Strohband
- Xiaoman Kang
- Mari N Olsen
- Chih Long Liu
- Lindsay A. Renfro
- Lisa Giulino-Roth
- Kara M. Kelly
- Tyler J. Bradshaw
- Maximilian Diehn
- Steve Yoon-Ho Cho
- Sharon M Castellino
- Ash A. Alizadeh
-
T072: Body-Size Normalisation of Metabolic Tumour Volume in Paediatric Hodgkin Lymphoma: Does MTV/BSA Improve Prognostic Stratification and Reclassify Smaller Children?
Abstract Talk in HL in Children and Adolescents (Sunday 08:00–09:15)
View full abstract at Hemasphere…
- Claire Gowdy
- Caron Strahlendorf
- Andrea C. Lo
- Yvonne Mbithi
- Carlos Uribe
- Arman Rahmim
- Fereshteh Yousefirizi
-
P073: Outcomes of Pediatric Hodgkin Lymphoma Patients treated with ABVD Regimen. A retrospective Cohort Study
View full abstract at Hemasphere…
- Hany Abdel Rahman
- Emad Moussa
- Mohamed Sedky
- Nesreen Ali
- Walaa El Sayed
- Maram Farouk
- Sally Talaat
- Hanaa Rashad
- Eman Khorshed
- Mohamed Saad Zaghloul
- Esraa Roshdy
- Madeha El Wakeel
-
P074: Outcomes of Second-Line EuroNet Salvage Regimens in Pediatric Patients with Relapsed and Primary Refractory Hodgkin Lymphoma
View full abstract at Hemasphere…
- Emad Moussa
- sara Badawy
- Asmaa Hamouda
- Asmaa Attia
- sally Talaat
- Hany Abdelrahman
- Nesreen Ali
- Mohamed Sedqy
- Nashwa Ezz El Din
- Walaa El Sayed
- Maram Farouk
- Mona Fakhry
- Ebtihal Shoukry
- yassin Taher
- Amr El Nashaar
- Mohamed Saad Zaghloul
- Eman Naguib
- Esraa Roushdy
- Madeha El Wakeel
- Reham Abdelaziz
- Alaa El Haddad
-
P075: Response Adapted Therapy of Pediatric Classic Hodgkin Lymphoma According to Modified EURO-NET Protocol-Single Center Experience
View full abstract at Hemasphere…
- Hany Abdel Rahman
- Nesreen Ali
- Mona Fakhry
- Maram Farouk
- Ebtihal Shoukry
- Nashwa Mahmoud
- Asmaa Attia
- Walaa El Sayed
- Mohamed Sedky
- Yassin Taher
- Riham Abdel Aziz
- Asmaa Hamoda
- Sally Talaat
- Eman Khorshed
- Mohamed Saad Zaghloul
- Esraa Roushdy
- Madeha El Wakeel
- Sarah Badawy
- Mohamed Kamal
- Emad Moussa
- Alaa El Haddad
-
P076: ATAXIA TELANGIECTASIA ASSOCIATED PEDIATRIC HODGKIN LYMPHOMA: HIGH RESPONSE RATES BUT SUBSTANTIAL NON RELAPSE MORTALITY
View full abstract at Hemasphere…
- Nesreen Ali
- Hany Abdelrahman
- Emad Moussa
- Nesreen Radwan
- Eman Khorshed
- Sara Badawy
- Walaa Elsayed
-
P077: Real-World Outcomes of IGEV Salvage Therapy in Relapsed or Refractory Pediatric Hodgkin Lymphoma: Challenges from a Resource-Limited Setting
View full abstract at Hemasphere…
- Walaa Elsayed
- Maram Salama
- Hany Abdelrahman
- Emad Moussa
- Yousef Medany
- Mohamed Saad Zaghloul
- Madeha El Wakeel
- Eman Khorshed
- Esraa Roshdy
- Nesreen Ali
-
P078: Baseline and Delta PET/CT Radiomics for Prognostic Stratification in Paediatric Hodgkin Lymphoma
View full abstract at Hemasphere…
- Claire Gowdy
- Caron Strahlendorf
- Andrea C. Lo
- Yvonne Mbithi
- Carlos Uribe
- Arman Rahmim
- Fereshteh Yousefirizi
-
P079: Survival benefit of brentuximab vedotin in classical Hodgkin lymphoma: a multicenter real-world study
View full abstract at Hemasphere…
- Wenhui Zhang
- Yuanyuan Wang
- Shaoxuan Hu
- Ming Jiang
- Shujuan Wen
- Weiping Liu
-
P080: Feasibility of tumor microenvironment analysis in pediatric and adolescent classical Hodgkin lymphoma by automated cyclic immunofluorescence staining
View full abstract at Hemasphere…
- Mira Albracht
- Fatih Yalcin
- Julia Richter
- Sarah Reinke
- Matthias Braun
- Marius Rohde
- Alexander Claviez
- Britta Maecker-Kolhoff
- Birgit Burkhardt
- Arndt Borkhardt
- Tobias Feuchtinger
- Anja Tröger
- Martin Ebinger
- Gabriele Escherich
- Dominik Schneider
- Jan-Henning Klusmann
- Anne Thorwarth
- Dieter Körholz
- Christine Mauz-Körholz
- Wolfram Klapper
-
P081: Allogeneic stem cell transplantation for multiply recurrent EBV-driven classic Hodgkin lymphoma arising in the setting of suspected activated PI3-kinase delta syndrome (APDS) associated with a novel variant: a case report spanning 13 years
View full abstract at Hemasphere…
- Joseph deBettencourt
- Rebecca Hale
- Jaclyn Schienda
- Amy Keating
- Marian Harris
- Leslie Lehmann
- Angela Feraco
Biology and pathology
-
T048: A Reproducible Mutation- versus Copy-Number-Enriched Genomic Axis Underlies Molecular Subtypes of Classic Hodgkin Lymphoma
Abstract Talk in Translating ctDNA into clinical routine (Sunday 10:45–12:00)
View full abstract at Hemasphere…
- Cara Paulina Lange
- Michael Yu Li
- Andrea Garofalo
- Tanja Zamrik
- Christian Reinhardt
- Bastian von Tresckow
- Mohammad Esfahani
- Ash A. Alizadeh
- Christian Steidl
- Tomohiro Aoki
- Stefan K. Alig
-
T046: Functional characterization of STAT6 mutations as oncogenic drivers in classical Hodgkin lymphoma (cHL)
Abstract Talk in Biology & Pathology (Sunday 12:15–13:30)
View full abstract at Hemasphere…
- Luisa Tasselli
- Rafael L. B. Coan
- Valentina Pensato
- Francois Le Dily
- Barbara G. Müller-Coan
- Valentina Pettirossi
- Enrique Blanco
- Alessandro Cupola
- Laura Pasqualucci
- Luciano Di Croce
- Enrico Tiacci
-
T047: Artificial intelligence predicts EBV status and reveals prognostic morphology phenotypes in advanced-stage classic Hodgkin lymphoma
Abstract Talk in Biology & Pathology (Sunday 12:15–13:30)
View full abstract at Hemasphere…
- Hishan Tharmaseelan
- Daniel Winderl
- Steffen Gretser
- Julia Richter
- Justin Ferdinandus
- Peter Borchmann
- Michael Altenbuchinger
- Wolfram Klapper
-
P049: Detection of traces of EBNA2 in the Microenvironment of Pediatric Classical Hodgkin Lymphoma Reveals Its Immunomodulatory Role
View full abstract at Hemasphere…
- Tamara Mangiaterra
- Karen Lindl
- Oscar Jimenez
- Elena De Matteo
- Paola Chabay
-
P050: VARIANT HISTOLOGY IN PEDIATRIC NLPBL: ADVERSE FEATURES MITIGATED BY R-CHOP, INCLUDING FEASIBLE EARLY-STAGE DE-ESCALATION
View full abstract at Hemasphere…
- Nesreen Ali
- Emad Moussa
- Eman Khorshed
- Mohamed Zaghloul
- Amr Elnashar
- Amr Abdalla
-
P051: Genetic tumor cell heterogeneity and genomic instability in classic Hodgkin lymphoma
View full abstract at Hemasphere…
- Sophie Klotz
- Bettina Budeus
- Frederik Schramm
- Lilian K. Beeck
- Marc A. Weniger
- Paul J. Bröckelmann
- Ralf Küppers
-
P052: Emerging role of SAMHD1 in anti-tumor immune responses and sensitivity to chemotherapy in classical Hodgkin lymphoma
View full abstract at Hemasphere…
- Dora Trogrlic
- Eleni Psaroudaki
- Georgios Mermelekas
- Ying Yang
- Erofili Bougka
- Christian Nordentoft
- Nikolas Herold
- Andreas Lundqvist
- Elias Drakos
- Georgios Rassidakis
-
P053: Development of CD30 CAR T-cells co-expressing an anti-PDL1.CD28 chimeric switch receptor for the treatment of r/r cHL
View full abstract at Hemasphere…
- Mikalai Katsin
- Dmitri Dormeshkin
- Alexandr Migas
- Hanna Klych
- Alexander Meleshko
- Konoplya Natalya
- Tatsiana Doroshenko
-
P054: Elucidation of transcriptomic tumor cell heterogeneity and microenvironment in classic Hodgkin lymphoma
View full abstract at Hemasphere…
- Frederik Schramm
- Sophie Klotz
- Bettina Budeus
- Lilian K. Beeck
- Marc A. Weniger
- Paul J. Bröckelmann
- Ralf Küppers
-
P055: RHOA Mutation Analysis Identifies Potential nTFHL Among Cases With Classic Hodgkin Lymphoma Morphology
View full abstract at Hemasphere…
- Rio Yamada
- Midori Filiz Nishimura
- Asami Nishikori
- Yoshito Nishimura
- Ritsuro Suzuki
- Yasuharu Sato
-
P056: Predictive significance of immunohistochemistry in patients with Hodgkin's lymphoma on the size of the tumor mass and IPS score
View full abstract at Hemasphere…
- Snežana Sretenović
- Danijela Jovanovic
- Predrag Djurdjevic
- Nikola Mirkovic
-
P057: Baseline PET Radiomics for Risk Stratification in Classic Hodgkin Lymphoma
View full abstract at Hemasphere…
- Andrew Heider
- Ajay Subramanian
- Veit Sandfort
- Natalie Park
- Lei Xing
- Richard Hoppe
- Ash A. Alizadeh
- Joseph Schroers-Martin
- Ranjana Advani
- Michael Binkley
-
P058: The TIGIT/CD155 Immune Checkpoint Axis in Classical Hodgkin Lymphoma: Clinical and Prognostic Implications
View full abstract at Hemasphere…
- Ombretta Annibali
- Teresa Marafioti
- Valeria Tomarchio
- Adheesh Ghosh
- Lara Antonelli
- Muntasser Alsharabati
- Salvatore Iachino
- Harriet Hunter
- Giulia Santoro
- Sugerdana Padmasri
- Antonella Bianchi
- Simona Spreafico
- Anna Crescenzi
- Luigi Rigacci
-
P060: Clinical relevance of serum TARC levels below 1000 pg/ml in Hodgkin lymphoma: a hidden biomarker?
View full abstract at Hemasphere…
- Fanni Borics
- Boglárka Dobó
- Anita Gulyás
- Dávid Tóthfalusi
- László Imre Pinczés
- Árpád Illés
- Zsófia Miltényi
-
P061: Familial Presentation of Classical Hodgkin Lymphoma in First-Degree Relatives
View full abstract at Hemasphere…
- Boglárka Dobó
- Dávid Tóthfalusi
- Fanni Borics
- László Imre Pinczés
- Árpád Illés
- Zsófia Miltényi
-
P062: Correlating 18FDG-PET/CT- and CT-derived Biomarkers to Neutrophil Extracellular Traps in Classical Hodgkin Lymphoma
View full abstract at Hemasphere…
- Emma Pettersson
- Alexander Korenyushkin
- Ashish Chauhan
- Sambit Tarai
- Jeremia Collin
- Rose-Marie Amini
- Daniel Molin
- Anna-Karin Olsson
- Håkan Ahlström
- Joel Kullberg
- Gunilla Enblad
-
P063: Genetic Clustering Reveals Biologic Similarities Across subgroups of Hodgkin Lymphoma, Primary Mediastinal Large B-Cell Lymphoma and Large B-Cell Lymphoma patients
View full abstract at Hemasphere…
- Jon Felix Rischewski
- Franziska Briest
- Julia Mattlener
- Daniel Noerenberg
- Julia Katharina Schleifenbaum
- Jessica Schneider
- Sophie Heidenreich
- Jan-Michel Heger
- Frederik Damm
- Sven Borchmann
-
P064: Time-of-Day Immunotherapy Administration and Outcomes in Classic Hodgkin Lymphoma
View full abstract at Hemasphere…
- Joseph Schroers-Martin
- Anthony Yu
- Austin Yeung
- Chandley Silin
- May Powell
- Michael Binkley
- Richard Hoppe
- Ranjana Advani
-
P065: Redefining Hodgkin lymphoma pathogenesis: the central and indispensable role of CD 4 T cells
View full abstract at Hemasphere…
- Arjan Diepstra
- Yajie Lei
- Sophie Teesink
- Wouter Plattel
- Lydia Visser
-
P066: The Role of CD59 in Mediating T Cell Rosette Formation in Classic Hodgkin Lymphoma
View full abstract at Hemasphere…
- Yajie Lei
- Rodrigo Martinez Alcala
- Annika Seitz
- Lydia Visser
- Arjan Diepstra
-
P067: Fragmentomics analysis to enhance ctDNA based risk stratification in Hodgkin Lymphoma
View full abstract at Hemasphere…
- Jessica Schneider
- Julia Mattlener
- Sophie Heidenreich
- Julia Katharina Schleifenbaum
- Max Freihammer
- Daniel Schütte
- Peter Borchmann
- Phillip Gödel
- Hyatt Balke-Want
- Christian Reinhardt
- Bastian von Tresckow
- Roland Schwarz
- Jan-Michel Heger
- Sven Borchmann
-
P068: Plasma Proteomic Profiling of Classical Hodgkin Lymphoma
View full abstract at Hemasphere…
- Ragnhild Risebro
- Jeremia Collin
- Johan Mattsson Ulfstedt
- Emma Pettersson
- Mats Hellström
- Ingrid Glimelius
- Mattias Berglund
- Gunilla Enblad
- Eva Freyhult
- Daniel Molin
-
P069: Analysis of circulating tumor DNA shows Epstein-Barr virus associated differences of mutagenic processes in classical Hodgkin lymphoma.
View full abstract at Hemasphere…
- Kristyna Kupcova
- Lubica Gaherova
- Adriana Velasova
- Maria Maco
- Iva Hamova
- Petr Nehasil
- Petra Zemankova
- Pavla Stepankova
- Alexandra Kredatusova
- Jana Markova
- Blanka Vackova
- Jan Koren
- Alice Sykorova
- Vit Prochazka
- Tomas Kozak
- Heidi Mocikova
- Ondrej Havranek
-
P070: Kinetics of PD-1 Blockade on Circulating CD8+ve T Cells After Exposure to low-dose Nivolumab
View full abstract at Hemasphere…
- Anu Korula
- Phaneendra Datari
- Arunkumar Arunachalam
- Vikram Mathews
Living beyond lymphoma
-
T092: Patients with a history of Hodgkin lymphoma have lower quality of life than matched comparators regardless of time elapsed since diagnosis
Abstract Talk in Living Beyond Lymphoma (Sunday 15:30–17:00)
View full abstract at Hemasphere…
- Sissel Johanne Godtfredsen
- Joachim Baech
- Mikkel Porsborg Andersen
- Harman Yonis
- Paw Jensen
- Peter Kamper
- Jacob H. Christensen
- Rasmus Bo-Dahl Sørensen
- Martin Hutchings
- Christian Torp-Pedersen
- Peter Sogaard
- Henrik Boggild
- Kristian H. Kragholm
- Tarec C. El-Galaly
-
T093: The MyHodgkin MyHealth App: patient-derived data for tracking Hodgkin Lymphoma survivorship
Abstract Talk in Living Beyond Lymphoma (Sunday 15:30–17:00)
View full abstract at Hemasphere…
- Nicole Wong Doo
- Angeline A. Josiah
- Georgia Klemm
- Lara Meli
- Alisha Ganesh
- Janlyn Falconer
- Ibrahim Tohidi-Esfahani
- Ryan Low
- Patrick Lawrence
- Pietro R Di Ciaccio
- Eve Propper
- Nicole Weekes
- Elizabeth Harris
- Nathan Chapman
- Sharon Winton
- Judith Trotman
-
P094: Evidence of Statistical Cure for Hodgkin Lymphoma With Contemporary Treatment: A Non-mixture Cure Model Analysis
View full abstract at Hemasphere…
- Jie Chen
- Yunhong Huang
- Ming Jiang
- Zhihua Yao
- Yue Wang
- Wenhui Zhang
- Jun Zhu
- Yuqin Song
- Shujuan Wen
- Yunfei Shi
- Weiping Liu
-
P095: Chemotherapy-induced peripheral neuropathy and quality of life among Hodgkin lymphoma survivors treated at an older age - A national cross-sectional study
View full abstract at Hemasphere…
- Renate B. Galleberg
- Kjersti Lia
- Unn Merete Fagerli
- Idun B Bø
- Knut B Smeland
- Siri Rostoft
- Marianne J Hjermstad
- Jeanette Johansen
- Sameer Bhargava
- Cecilie E Kiserud
- Kari Sørland
- Floortje Mols
- Øystein Fluge
- Alexander Fosså
-
P096: Frailty as a predictor of survival in older patients with classical Hodgkin lymphoma: A retrospective, multicenter study from the RELINF Spanish Lymphoma Registry of the GELTAMO Spanish Lymphoma Group
View full abstract at Hemasphere…
- Eva Domingo-Doménech
- Carmen Martinez Muñoz
- Rosa Maria Rodriguez Nuñez
- Blanca Sanchez Gonzalez
- Miriam Moreno
- David Alonso Castronuño
- Maria Jimena Cannata-Ortiz
- Pilar Gomez Prieto
- Laurentino Benito
- Tamara Torrado
- Joan Buch
- Carolina Arevalo
- Juan Carlos Caballero
- Nazaret Dominguez
- Raquel Santiago
- Isabel Gonzalez-Gascon
- Maria Moya Arnao
- Cecilia Carpio
- Maria Dolores Gutierrez-Meca Maestre
- Luis Antonio Lopez Gomez
- Eukene Gainza
- Maria Rocio Figueroa Mora
- Paula Fernandez-Caldas
- Paola Villafuerte Gutierrez
- Samuel Romero
- Belen Navarro
- Izaskun Zeberio Etxetxipia
- Emilia Pardal
- Antonio Gutierrez
- Eva Donato
- Javier Nuñez
- Teresa Cobo
- Ramón Garcia Sanz
- Maria Isabel Gomez Roncero
- Cristina Barrenetxea
- Haridian de la Nuez
- Andrea Dorado Lopez
- Roberto Trelles
- Luis Ignacio Sanchez Val
- Sofia Martin-Consuegra
- Maria Luisa Bengochea
- Carmen Maria Alonso Prieto
- Elena Ramila
- Maria Jesus Peñarrubia
- Alfonso Ortiz
- Ignacio Mahillo
- Raul Cordoba
-
P097: The Psychological Impact of Lung Cancer Screening in Hodgkin Lymphoma Survivors
View full abstract at Hemasphere…
- Morgan Brusven
- Tania Seale
- Kim Linton
- Rachel Broadbent
-
P098: Impact of Exercise interventions during chemotherapy in functional capacity and patient-reported outcomes in patients with Hodgkin lymphoma
View full abstract at Hemasphere…
- Maren Martinez de Rituerto Zeberio
- Begoña Mendibil Esquisabel
- Helena Goicoechea Pellejero
- Mikel Tous Espelosin
- Iñigo Olazabal Eizaguirre
- Jon Madinabeitia
- June Iriondo Alzola
- Sara Maldonado Martín
- Izaskun Zeberio Etxetxipia
-
P099: Factors Associated with Survivorship Care Engagement Among Pediatric Hodgkin Lymphoma Survivors
View full abstract at Hemasphere…
- Ksenya Shliakhtsitsava
- Anandini Rao
- Lynn Gargan
- Cindy Cochran
- Tanya Watt
- Eman Rettig
- Daniel Bowers
- Rebecca Eary
- Amy Hughes
-
P100: Long-term follow up after Lymphoma treatment in young adults
View full abstract at Hemasphere…
- Urska Rugelj
- Lorna Zadravec Zaletel
- Danijela Štrbac
- Miha Toplak
Advanced stages
-
T001: CHOP/miniCHOP And Tislelizumab in EldeRly patients with classical Hodgkin Lymphoma (cHL). A report of the phase II CATER-HL trial (HD12) from the Australasian Lymphoma and Leukaemia Group (ALLG)
Abstract Talk in Advanced Stages (Sunday 17:00–18:30)
View full abstract at Hemasphere…
- Tara Cochrane
- Sze Ting Lee
- Robin Gasiorowski
- Shane A Gangatharan
- Fernando Roncolato
- William EP Renwick
- Jock Simpson
- Amanda Johnston
- Uwe Hahn
- Philip Wong
- Masa Lasica
- Ann Solterbeck
- Robert Traficante
- Sally Mapp
- Bianca Devitt
- Dhvani Pandya
- Julia Carlson
- Tracey Gerber
- Mark Hertzberg
- Eliza Hawkes
- Colm Keane
-
T002: Simplified Geriatric Assessment (sGA) in Older Patients With Classical Hodgkin Lymphoma (cHL): The Prospective ELDHL Project of the Fondazione Italiana Linfomi (FIL)
Abstract Talk in Advanced Stages (Sunday 17:00–18:30)
View full abstract at Hemasphere…
- Vittorio Ruggero Zilioli
- Francesco Merli
- Alessandra Tucci
- Stefano Luminari
- Giuseppe Colloca
- Cristina Muzi
- Benedetta Puccini
- Chiara Pagani
- Candida Vitale
- Francesca Gaia Rossi
- Erika Meli
- Anna Guidetti
- Simone Maifredi
- Dario Marino
- Alberto Fabbri
- Nilla Maschio
- Manuel Gotti
- Andrea Bernardelli
- Salvatrice Mancuso
- Anna Mele
- Guido Gini
- Ilaria Del Giudice
- Sara Bigliardi
- Elisabetta Scarpa
- Barbara Botto
- Gloria Margiotta-Casaluci
- Andrea Maria Soccodato
- Monica Tani
- Arcangelo Liso
- Michał Kurlapski
- Leonardo Flenghi
- Anna Merli
- Antonello Sica
- Francesca Ricci
- Francesca Perutelli
- Roberta Battistini
- Andrés José Maria Ferreri
- Daniele Laszlo
- Francesco Gaudio
- Manuela Zanni
- Emanuele Cencini
- Valentina Tabanelli
- Luca Guerra
- Claudio Agostinelli
- Luigi Marcheselli
- Caterina Mammi
- Michele Spina
- Annalisa Arcari
-
T003: Durable Remissions and Late Immune-Related Toxicities After Frontline Pembrolizumab + AVD in Classic Hodgkin Lymphoma
Abstract Talk in Advanced Stages (Sunday 17:00–18:30)
View full abstract at Hemasphere…
- Ryan Lynch
- Thomas Kuczmarski
- Chaitra Ujjani
- Christina Poh
- Edus Warren
- Stephen Smith
- Mazyar Shadman
- Brian Till
- Vikram Raghunathan
- Yolanda Tseng
- Hongyan Du
- Heather Rasmussen
- Jenna Voutsinas
- Ajay Gopal
-
P004: Low-dose nivolumab combined with AVD chemotherapy (Nivo40-AVD) for advanced classic Hodgkin lymphoma: interim results
View full abstract at Hemasphere…
- Mobil Akhmedov
- Pervin Zeynalova
- Mariya Vernyuk
- Sergey Semochkin
- Liliya Khairullina
- Irina Cherkashina
- Alevtina Chervontseva
- Vladimir Lunin
- Alexander Fedenko
- Andrey Kaprin
-
P005: Real-World Tolerability and Efficacy of BrECADD in Advanced-Stage Hodgkin Lymphoma: A Multicenter Brazilian Experience
View full abstract at Hemasphere…
- Giovanna Peruzini
- Matheus Garcia
- Ruddy de Barros
- Thiana de Moura
- Rafaella Samico
- Natalia Zing
- Raquel Brito
- Vanessa Bovolenta
- Jayr Schimdt
- Arthur Braga
- Thais Fisher
- Talita Silveira
-
P006: BrECADD in Three Days: Condensing an Intensive First-Line Regimen in Classic Hodgkin Lymphoma
View full abstract at Hemasphere…
- Christian Peter Jaworek
- Maja Supprian
- Paul J. Bröckelmann
- Hishan Tharmaseelan
- Justin Ferdinandus
- Dennis Eichenauer
- Anne Sophie Robertz
- Janina Jablonski
- Vincent Combüchen
- Jan-Oliver Staak
- Karin Töpelt
- Jan-Michel Heger
- Jon Felix Rischewski
- Jannik Stemler
- Wolfram Klapper
- Bastian von Tresckow
-
P007: Six Cycles of Pembrolizumab (PEM) Induction Followed by Abbreviated AVD: A Phase II Trial of Front-Line PET-adapted Therapy in Early Unfavorable and Advanced-Stage Classic Hodgkin Lymphoma (cHL)
View full abstract at Hemasphere…
- Megan Melody
- Hatice Savas
- Joseph Schroers-Martin
- Reem Karmali
- Yangruijue Ma
- Caroline Mangan
- Wajiha Zehra
- Ryan Avery
- Kenneth Carson
- Fahad Faruqi
- Habib Shaikh
- Ruohui Chen
- Renee Cheng
- Leo Gordon
- Ranjana Advani
- Jane Winter
-
P008: Real-world experience with first-line Nivolumab-AVD in advanced-stage Classical Hodgkin Lymphoma
View full abstract at Hemasphere…
- Francisca De Asis Maria Hernández Mohedo
- Laura Curras Sanchez
- Laura Jimenez Blanco
- Ana Isabel Martinez Conejo
- Maria Teresa Escudero Soler
- Maria Luisa Rubio de la Rubia
- Carlos Ramos Font
- Jose Manuel Puerta Puerta
-
P009: PRECISE-HL Trial: Personalized Reduction of Chemotherapy Intensity through ctDNA Evaluation in Advanced Hodgkin Lymphoma
View full abstract at Hemasphere…
- Ryan Lynch
- David Russler-Germain
- Joseph Schroers-Martin
- Alison Moskowitz
- Reid Merryman
- Azra Borogovac
- Hongyan Du
- Heather Rasmussen
- Ranjana Advani
- Ash A. Alizadeh
- Philippe Armand
- Nancy Bartlett
- Alex Herrera
- Sarah Rutherford
- David Kurtz
- Ted Gooley
- Jenna Voutsinas
- Ajay Gopal
-
P010: Frontline Escalation to BrECADD in Advanced Hodgkin Lymphoma: Multicenter Real-World Experience
View full abstract at Hemasphere…
- Tzvika Porges
- Tsofia Levi
- Tareq Buqai
- Eldad J Dann
-
P011: Interim analysis of the A-AVD PET2 adapted in patients with stage IV classical Hodgkin lymphoma. The AVATAR program
View full abstract at Hemasphere…
- Andrea Visentin
- Alessandro Cellini
- Francesco Angotzi
- Martina De Ferrari
- Mattia D'Antiga
- Anna Giordano
- Nicolo' Danesin
- Marco Pizzi
- Gaia Grassetto
- Federica Vianello
- Francesco Piazza
- Andrea Gallamini
- Livio Trentin
-
P012: KEYNOTE-204 final analysis: An open-label, phase 3 study of pembrolizumab (pembro) versus brentuximab vedotin (BV) in relapsed or refractory (R/R) classic Hodgkin lymphoma (cHL)
View full abstract at Hemasphere…
- John Kuruvilla
- Armando Santoro
- Jan Walewski
- Robin Gasiorowski
- Nathalie Johnson
- Vladimir Melnichenko
- Valeria Buccheri
- Patricia Giacon
- Laura Maria Fogliatto
- Iara Goncalves
- Guilherme Perini
- Sergey Alekseev
- Neta Goldschmidt
- Iryna Kriachok
- Judyta Strzala
- Michael Dickinson
- Anna Lojko-Dankowska
- Andrew McDonald
- Muhit Ozcan
- Razi Ghori
- Doyun Park
- Rushdia Yusuf
- Pier Luigi Zinzani
-
P013: Subcutaneous Pembrolizumab (Pembro) in Relapsed or Refractory Classic Hodgkin Lymphoma (cHL) or Primary Mediastinal Large B-cell Lymphoma (PMBCL): Additional Follow-Up From a Phase 2 Study
View full abstract at Hemasphere…
- Elizabeth H. Phillips
- Gabriel Barragán Ibáñez
- Ewa Paszkiewicz-Kozik
- Wojciech Jurczak
- Mauricio Chandia Cabas
- Sergio Portiño
- Elifcan Aladag Karakulak
- Sebastian Giebel
- Anna Sureda
- Tae Min Kim
- Brenda González-García
- Norma Gutiérrez
- Sebastian Hidalgo
- Kirit Ardeshna
- Antonia Rodríguez Izquierdo
- Bastian von Tresckow
- Gina Song
- Jessica Flynn
- Katherine Ryland
- Rushdia Yusuf
- Muhit Ozcan
-
P014: Changes in Patient Reported Outcomes and Treatment Tolerance with a Structured Diet and Exercise Plan
View full abstract at Hemasphere…
- Michele Stanchina
- Melissa Lopez-Pentecost
- Akina Natori
- Juan Alderuccio
- Asaad Trabolsi
- Alvaro Alencar
- Emily Panzner
- Grey Freylersythe
- Tracy Crane
- Craig Moskowitz
-
P015: High efficacy and acceptable toxicity of BrECADD regimen in advanced-stage classical Hodgkin lymphoma
View full abstract at Hemasphere…
- Heidi Mocikova
- Lubica Gaherova
- Barbara Brizova
- Katerina Steinerova
- Jozef Michalka
- Zdenek Kral
- Marie Lukasova
- Vit Prochazka
- Alice Sykorova
- Pavla Stepankova
- Katarina Hradská
- Juraj Duras
- Blanka Vackova
- Jan Koren
- Tomas Kozak
-
P016: FENIX Score: A Novel PET-Derived Signature Predicting Neurotoxicity in Advanced Hodgkin Lymphoma Treated with A+AVD
View full abstract at Hemasphere…
- Matteo Cristante
- Federico Fallanca
- Teresa Calimeri
- Andrés José Maria Ferreri
- Fabrizio Marino
-
P017: Frontline Use of Nivolumab with Doxorubicin, Vinblastine, and Dacarbazine inAdvanced-Stage Classical Hodgkin Lymphoma: A Real-World Analysis
View full abstract at Hemasphere…
- Ľubica Gahérová
- Tomáš Kozák
- Jozef Michalka
- Marcela Cermanová
- Zdeněk Král
- Blanka Vacková
- Jan Kořen
- Alice Sýkorová
- Katarína Hradská
- Kateřina Steinerová
- Marie Lukášová
- Heidi Móciková
-
P018: Interim PET remains clinically informative during frontline nivolumab-based therapy in advanced-stage classical Hodgkin lymphoma
View full abstract at Hemasphere…
- Anna Kravtsova
- Daria Koroleva
- Olga Shchetsova
- Madina Bagova
- Aminat Magomedova
- Oleg Margolin
- Ekaterina Gitelzon
- Alexey Subbotin
- Evgeny Zvonkov
- Yana Mangasarova
-
P019: Real-World Treatment Options and Outcomes of Hodgkin Lymphoma in Hungary
View full abstract at Hemasphere…
- Zsófia Miltényi
- Fanni Borics
- Dávid Tóthfalusi
- Boglárka Fülöp-Dobó
- László Imre Pinczés
- Árpád Illés
-
P020: Efficacy and Safety of the combination of Programmed Death -1 inhibitors (PD-1i) with chemotherapy for the treatment of classical Hodgkin’s Lymphoma (cHL). A single center experience
View full abstract at Hemasphere…
- Kassiani Papanastassi
- Pavlos-Panagiotis Triantafyllou
- Chara Giatra
- Natassa – Eleni Loutsidi
- Alexandros Tolias
- Antonis Patrinos
- Eleni Tsitziloni
- Leonidas Kotsifas
- Evaggelia Giannikou
- Maria Vasilleiou
- Christos Massaoutis
- Phoebi Rondogianni
- Ioannis Baltadakis
- Maria Bouzani
-
P022: Association of Patlak-derived dynamic FDG PET parameters with Deauville response categories and kinetic heterogeneity of residual PET-positive findings in classical Hodgkin lymphoma: a prospective single-center pilot study
View full abstract at Hemasphere…
- Gregor Horňák
- Veronika Hanáčková
- Marie Lukášová
- Jaroslav Ptáček
- Vít Procházka
- Milan Kamínek
-
P023: Real-World Effectiveness and Safety of the BrECADD Regimen in Advanced Hodgkin Lymphoma. A Multicenter Observational Study of the Polish Lymphoma Research Group.
View full abstract at Hemasphere…
- Justyna Rybka
- Tomasz Wróbel
- Anna Czyż
- Kacper Bułdyś
- Iwona Grygoruk-Wiśniowska
- Monika Długosz-Danecka
- Mateusz Sawicki
- Katarzyna Malesa
- Jarosław Dybko
- Ewa Paszkiewicz-Kozik
- Michał Kurlapski
- Kamila Kruczkowska-Tarantowicz
- Agnieszka Kołkowska-Leśniak
- Ewa Lech-Marańda
- Emilia Migryt-Rogala
- Justyna Gil
- Agnieszka Kopacz
- Anna Kopińska
- Agnieszka Janus
- Agnieszka Giza
- Jan Maciej Zaucha
-
P024: Anthracycline-containing regimens confer better survival in risk-matched, advanced stage older patients with classic Hodgkin lymphoma; comorbidity, not age, predicts cardiac toxicity
View full abstract at Hemasphere…
- Aisling Barrett
- Amy Kirkwood
- Pam McKay
- Wendy Osborne
- Nimish Shah
- Fatima Jamil
- Ravindu De Silva
- Joanna Fawcett
- Nicola Crosbie
- Jacinta Hardman
- Sarah Idris
- ChenXi Lee
- Edward Truelove
- Amjad Hmaid
- Sunil Iyengar
- Laura McDonald
- Fiona Miall
- Heather Laing
- Georgina Talbot
- Syed Hasan
- Shuyang Dai
- Anna Santarsieri
- Sai Lon Wann
- Maria Marzolini
- James Paterson
- Sarah Lawless
- David Waddell
- Rachel Trickey
- Tessa Davies
- Vivek Radhakrishnan
- Srishma Sridhar
- Elizabeth H. Phillips
- Chiara Dallatorre
- Peter Toth
- Pierre McCarthy
- Emily Chernucha
- Moitreyo Pandit
- Laura Percy
- Jack Easton
- Rory McCulloch
- Julia Wolf
- Matthew Wells
- David Quinn
- Andrea Kuhnl
- Charlotte Subklewe
- Lucy Cook
- Oscar Atkins
- Eve Gallop-Evans
- Katja Williams
- Cathy Burton
- Graham P. Collins
-
P025: Validation of the Hodgkin lymphoma Simplified Frailty Score for Patients Receiving Modern Regimens
View full abstract at Hemasphere…
- Katherine Sobol
- Efrat Luttwak
- Tiffany Chang
- Nivetha Ganeson
- Pallawi Torka
- Alison Moskowitz
-
P026: Fitness-adapted, pembrolizumab-based therapy for untreated classical Hodgkin Lymphoma (cHL) patients (Pts) 60 years of age and above: a multicenter prospective study
View full abstract at Hemasphere…
- Craig Portell
- Bethany Horton
- David Brighton
- Jakub Svoboda
- Victor Orellana-Noia
- Andrew M. Evens
-
P027: Cost-effectiveness analysis of N-AVD vs BrECADD in advanced-stage classic Hodgkin lymphoma
View full abstract at Hemasphere…
- Jowon Laura Kim
- Amar H. Kelkar
- Susan Parsons
- Alison Moskowitz
- Kishan Patel
- Adrienne Nedved
- Arushi Khurana
- JC C. Villasboas Bisneto
- Jonas Paludo
- Jithma P. Abeykoon
- Yun Kyoung Tiger
- Paul J. Hampel
- Yucai Wang
- Yi Lin
- N. Nora Bennani
- Luis F. Porrata
- Gita Thanarajasingam
- Carrie A. Thompson
- Patrick B. Johnston
- Ivana N. Micallef
- Thomas M. Habermann
- Thomas E. Witzig
- Philippe Armand
- Stephen M. Ansell
- Urshila Durani
-
P028: First-line BrECADD in routine clinical practice: excellent treatment deliverability and early efficacy in advanced-stage classical Hodgkin lymphoma
View full abstract at Hemasphere…
- Ida Hude Dragičević
- Klaudia Babić Čukman
- Sandra Bašić-Kinda
- Barbara Dreta
- Dino Dujmović
- Josip Batinić
- Margareta Dobrenić
- Lea Galunić-Bilić
- Igor Aurer
-
P029: Ten-year follow-up of ECHELON-1: overall survival and long-term safety with Brentuximab vedotin plus AVD versus ABVD in patients with previously untreated advanced classic Hodgkin lymphoma
View full abstract at Hemasphere…
- Stephen M. Ansell
- David J. Straus
- Joseph M. Connors
- Wojciech Jurczak
- Won Seog Kim
- Andrea Gallamini
- Marco Picardi
- Tatyana Feldman
- Kerry J. Savage
- Radhakrishnan Ramchandren
- Pier Luigi Zinzani
- Jeremy S. Abramson
- Graham P. Collins
- Jonathan W. Friedberg
- Andrew Grigg
- Mehmet Turgut
- Martin Hutchings
- Ranjana Advani
- Adriana Scheliga
- Andrew M. Evens
- Rizvan Bush
- Farhad Sedarati
- Fei Jie
- Michelle Fanale
- John Radford
-
P030: Outcome and Prognostic Value of PET-2 in Stage IV Classical Hodgkin Lymphoma Treated with Frontline Brentuximab Vedotin Plus AVD: A Real-World Multinational GELTAMO-GATLA Study
View full abstract at Hemasphere…
- Jose Ignacio Trucco
- Marta Peña
- Maria Teresa Marti
- Laura Korin
- Maria Rocio Figueroa Mora
- Carmen Martinez
- Guadalupe Antelo Perez
- Marta Zerga
- Maria Belen Navarro
- Carolina Mahuad
- Cecilia Carpio
- Carmen Maria Alonso Prieto
- Lorena Fiad
- Maria Jimena Cannata-Ortiz
- Malena Rocca
- Nicolas Kellenher
- Mariana Rosenhain
- Blanca Sanchez Gonzalez
- Luciano Salvano
- Lucia Villalon Blanco
- Javier Romano
- Veronica Musso
- Alessandra Comai
- Fernando Warley
- Carlos Santorum
- Florencia Negri Aranguren
- Maria Orlova
- Amalia Cerutti
- Valeria Drouet
- Lautaro Sardu
- Trinidad Viviani
- Julia Valerga Couste
- Eva Domingo-Doménech
- Anna Sureda
- Astrid Pavlovsky
-
P031: Multistate Modeling of Disease Trajectories for Advanced-Stage Hodgkin Lymphoma Patients Receiving PET Response-Adapted Therapy
View full abstract at Hemasphere…
- Zhu (Jenny) Cui
- Hocine Tighiouart
- Nicholas Counsell
- Sara Rossetti
- Jenica Upshaw
- Amy Kirkwood
- Hongli Li
- Ranjana Advani
- Olivier Casanovas
- James Cerhan
- Massimo Federico
- Andrea Gallamini
- Hervé Ghesquieres
- Eliza Hawkes
- David Hodgson
- Martin Hutchings
- Peter Johnson
- Brian Link
- Eric Mou
- John Radford
- Kerry J. Savage
- Deborah Stephens
- Pier Luigi Zinzani
- Matthew Maurer
- Cedric Rossi
- Andrew M. Evens
- Susan Parsons
- Angie Mae Rodday
-
P032: ABVD versus a risk-stratified and a response adapted strategy– addressing the dilemma in Advanced Hodgkin Lymphoma: A Phase III Randomized Study
View full abstract at Hemasphere…
- Hasmukh Jain
- Aravind Padmanabhan
- Alok Shetty
- Lingaraj Nayak
- Bhausaheb Bagal
- Jayashree Thorat
- Thomas Eipe
- Supriya More
- Nisha Khatavkar
- Prasanth Ganesan
- Sreeraj Vasudevan
- Jayant Goda
- Sumeet Gujral
- Tanuja Shet
- Jyothi Kode
- Archi Agrawal
- Venkatesh Rangarajan
- Sneha Shah
- Neha Sharma
- Epari Sridhar
- Siddhartha Laskar
- Manju Sengar
-
P033: Evaluating the outcomes of elderly Hodgkin Lymphoma patients: a focus on sequential Brentuximab-AVD
View full abstract at Hemasphere…
- Alessandro Cellini
- Francesco Angotzi
- Martina De Ferrari
- Nicolo' Danesin
- Mattia D'Antiga
- Arianna Bevilacqua
- Anna Giordano
- Marco Pizzi
- Filippo Crimi'
- Gaia Grassetto
- Federica Vianello
- Francesco Piazza
- Livio Trentin
- Andrea Visentin
-
P034: Netupitant/palonosetron for prevention of chemotherapy-induced nausea and vomiting in Hodgkin lymphoma treated with ABVD or BV-AVD: a single-centre observational study
View full abstract at Hemasphere…
- Alessandro Cellini
- Francesco Angotzi
- Ivan Zatta
- Martina De Ferrari
- Andrea Serafin
- Arianna Bevilacqua
- Nicolo' Danesin
- Giovanni Leone
- Mattia D'Antiga
- Anna Giordano
- Francesco Piazza
- Francesca Temporin
- Livio Trentin
- Andrea Visentin
-
P035: In-Field Recurrence Patterns Following Consolidation Radiotherapy after BrECADD in Advanced-Stage Hodgkin Lymphoma: A Secondary Analysis of the Randomized Phase 3 GHSG HD21 Trial
View full abstract at Hemasphere…
- Johannes Rosenbrock
- Maja Supprian
- Michael Oertel
- Justin Ferdinandus
- Hishan Tharmaseelan
- Christian Peter Jaworek
- Simone Ferdinandus
- Jasmin Weindler
- Paul J. Bröckelmann
- Hendrik Dapper
- Carsten Kobe
- Michael Fuchs
- Emmanouil Fokas
- Peter Borchmann
- Hans Theodor Eich
- Christian Baues
-
P036: Interim PET-Adapted De-escalation Chemotherapy Regimen for Advanced Stage Classical Hodgkin Lymphoma Using Brentuximab Vedotin, Pembrolizumab, Doxorubicin, and Dacarbazine: Phase 2 Study — Updated Follow-up
View full abstract at Hemasphere…
- Hun Ju Lee
- Gregory Ravizzini
- Jennifer Ramos
- Javier Retamales
- Ayushi Chauhan
- Luis Fayad
- Ranjit Nair
- Jason Westin
- Jared Henderson
- Christopher Flowers
- Michael Wang
- Luis Malpica
-
P037: PET-Adapted EACODD-14 Regimen in Early Unfavorable and Advanced Stages of Classical Hodgkin Lymphoma: Efficacy and Survival in the Multicenter HL-Russia-1 Study
View full abstract at Hemasphere…
- Nikita Shorokhov
- Elena Demina
- Gayane Tumyan
- Valeria Spirko
- Elena Pavluchenko
- Kamil Kaplanov
- Alena Bobrova
- Elena Baryakh
- Diana Ivanova
- Natalia Mikhailova
- Evgeniya Borzenkova
- Tatyana Pospelova
- Maria Voytko
- Olga Smirnova
- Elsa Kankumasheva
- Elsa Siraeva
- Vitaliy Kanin
- Alexandra Saidullaeva
- Arina Adolf
- Irina Matveeva
- Nikita Mochkin
- Vladimir Melnichenko
- Vladislav Sarzhevskiy
-
P038: Frontline nivolumab-AVD in older patients with advanced classical Hodgkin lymphoma: real-word experience from a single Italian centre
View full abstract at Hemasphere…
- Tanja Lazic
- Stefano Luminari
- Alberto Bavieri
- Silvia Gambara
- Maria Elena Nizzoli
- Laura Arletti
- Angela Ferrari
- Fiorella Ilariucci
- Francesco Merli
-
P039: Has Frontline Brentuximab Vedotin Plus AVD Altered the Historical Adverse Prognostic Impact of Stage IV Disease in Classical Hodgkin Lymphoma? A Dual-Center Real-World Experience
View full abstract at Hemasphere…
- Martha Cecilia Berliner
- Tanja Lazic
- Roberta Sciarra
- Alessandro Mazzacane
- Sofia Pedrali
- Nicolò Rampi
- Chiara Rusconi
- Luca Arcaini
- Stefano Luminari
- Manuel Gotti
-
P040: Hyperbilirubinemia in Classical Hodgkin Lymphoma: Impact of Severity on Hepatic Recovery and Clinical Outcomes
View full abstract at Hemasphere…
- Yash Patel
- Kavitha Lakshmi
- Anu Korula
- Vikram Mathews
-
P041: INTERIM AND END-OF-TREATMENT (EOT) PET/CT ASSESSMENT AFTER NIVOLUMAB, DOXORUBICIN, VINBLASTINE, AND DACARBAZINE (N-AVD) IN ADVANCED-STAGE CLASSICAL HODGKIN LYMPHOMA (CHL): A SINGLE-CENTER EXPERIENCE
View full abstract at Hemasphere…
- Piperidou Alexia
- Athanasios Liaskas
- Anastasia Kopsaftopoulou
- Maria Dimitrakoudi
- Eliana Konstantinou
- Marina Belia
- Maria Arapaki
- Rodanthi Fioretzaki
- Aikaterini Kolotsiou
- Alexandros Machairas
- Georgia Poultsaki
- Chryzovalantou Chatzidimitriou
- John Asimakopoulos
- Angeliki Georgopoulou
- Calliope Zerzi
- Panayiotis Tsaftaridis
- Fotios Panitsas
- Aikaterini Benekou
- Panayiota Petsa
- Helen Plata
- Aikaterini Bitsani
- Maria Dimou
- Marina Siakantaris
- Maria Angelopoulou
- Theodoros Vassilakopoulos
-
P042: Association of quantitative FDG-PET parameters and serum TARC with outcome in advanced classic Hodgkin lymphoma: A biomarker analysis of the EORTC-1537-COBRA trial
View full abstract at Hemasphere…
- Sophie Teesink
- Lydia Visser
- Laure Musekera
- Anna Sureda
- Susana Carvalho
- Andrey Vranovsky
- Annika Loft
- Anne Arens
- Sanne Tonino
- Ward Sents
- Cédric Mallien
- Berthe Aleman
- Walter Noordzij
- Catherine Fortpied
- Martin Hutchings
- Arjan Diepstra
- Wouter Plattel
-
P043: LUNG FUNCTION ASSESSMENT BY DIFFUSING CAPACITY OF THE LUNGS FOR CARBON MONOXIDE (DLCO) MEASUREMENT IN PATIENTS WITH CLASSICAL HODGKIN LYMPHOMA RECEIVING FIRST-LINE TREATMENT WITH NIVOLUMAB-AVD
View full abstract at Hemasphere…
- Athanasios Liaskas
- Alexia Piperidou
- Georgia Poultsaki
- Maria Dimitrakoudi
- Anastasia Kopsaftopoulou
- Rodanthi Fioretzaki
- Alexandros Machairas
- Marina Belia
- Maria Arapaki
- Eliana Konstantinou
- Giannis Assimakopoulos
- Panayiotis Tsaftaridis
- Fotios Panitsas
- Aikaterini Bitsani
- Maria Dimou
- Marina Siakantaris
- Maria Angelopoulou
- Theodoros Vassilakopoulos
-
P044: HIV-associated Hodgkin lymphoma: real-world treatment outcomes and infectious complications – a multicentre study by the Polish Lymphoma Research Group
View full abstract at Hemasphere…
- Agnieszka Giza
- Magdalena Zapala
- Joanna Drozd-Sokolowska
- Magdalena Witkowska
- Jan Maciej Zaucha
- Malgorzata Sobczyk-Kruszelnicka
- Anastazja Szlauer-Stefanska
- Anna Kopinska
- Magdalena Zawartko
- Magdalena Witak- Jedra
- Kamil Wisniewski
- Kamil Wdowiak
- Jarosław Grzyb
- Anna Parfieniuk-Kowerda
- Natalia Leonczuk
- Alicja Wandalowicz
- Monika Joks
- Justyna Rybka
- Judyta Strzala
- Agnieszka Szeremet
- Aleksandra Szymczak
- Marcin Czarnecki
- Marta Głuchowska
- Jarosław Dybko
- Dagmara Zimowska-Curylo
- Ewa Lech-Maranda
- Tomasz Sacha
- Jan Maciej Zaucha
- Milosz Parczewski
- Monika Bociaga-Jasik
-
P045: Frontline BV-AVD in Classical Hodgkin Lymphoma: A Multicenter Real-World Comparison with the ABVD Regimen
View full abstract at Hemasphere…
- Fatma Keklik Karadag
- Merve Yuksel
- Umut Yılmaz
- Meral Ulukoylu Menguc
- Denis Çetin
- Ajda Gunes
- Batuhan Bulan
- Taner Tan
- Sureyya Yigitkaya
- Hacer Berna Afacan Ozturk
- Ezel Elgün
- Deniz Gören
- Ulviyya Hasanzade
- Hale Bulbul Dilmen
- Utku Iltar
- Merve Ecem Erdogan Yon
- Guldane Cengiz Seval
- Ozan Salim
- Orhan Kemal Yücel
- Ekin Kircali
- Zafer Serenli Yeğen
- Haşim Atakan Erol
- Ayse Uysal
- Burak Deveci
- Omur Kayıkcı
- Zehra Narli Özdemir
- Esin Oğuz Kozan
- Mehmet Baysal
- Ayse Hilal Eroğlu Küçükdiler
- Zuhal Demirci
- Irfan Yavasoglu
- Pelin Aytan
- Deniz Ozmen Ibis
- Murat Ozbalak
- Fahir Ozkalemkas
- Ahmet Kursad Gunes
- Ömür Gökmen Sevindik
- Gulsum Ozet
- Zafer Gulbas
- Olga Meltem Akay
- Muhlis Cem Ar
- Ahmet Emre Eskazan
- Elif Birtas Atesoglu
- Burhan Ferhanoglu
- Guray Saydam
- Muhit Ozcan
- Ozgur Mehtap
NLPHL
-
T101: Single-Nuclei and Spatial Transcriptomic Analysis of Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)
Abstract Talk in NLPHL (Monday 09:30–10:30)
View full abstract at Hemasphere…
- Hua Dong
- Samira Rambow-Makhzami
- Max Vorneweg
- Finn Wichmann
- Philipp Jurmeister
- Ina Bühnen
- Andreas Rosenwald
- Wolfram Klapper
- Bastian von Tresckow
- Christian Reinhardt
- Frederik Klauschen
- Heinz-Wolfram Bernd
- Martin-Leo Hansmann
- Dennis Eichenauer
- Sylvia Hartmann
- Florian Rambow
-
T102: Malignant LP cells build a stroma-poor, avascular niche that concentrates IDO1+ macrophages and excludes regulatory T cells in NLPHL and THRLBCL
Abstract Talk in NLPHL (Monday 09:30–10:30)
View full abstract at Hemasphere…
- Ilja Kalashnikov
- Suvi-Katri Leivonen
- Kerttu Kalander
- Matias Autio
- Johannes Dunkel
- Anniina Färkkilä
- Sirpa Leppä
-
P103: Data Scarcity in Rare Lymphoma: Synthetic Patient Generation and Survival Analysis in NLPHL
View full abstract at Hemasphere…
- Gabriele Santangelo
- Eleonora Fresi
- Virginia Ferretti
- Martha Berliner
- Sofia Pedrali
- Alessandro Mazzacane
- Arianna Dagliati
- Manuel Gotti
-
P104: Pembrolizumab In Relapsed/Refractory Nodular Lymphocyte-Predominant Hodgkin Lymphoma: A Case Report
View full abstract at Hemasphere…
- Pedro Rodrigues Santos
- Francesca Pierdomenico Maciel
- Pedro Sousa
- Gonçalo Esteves
- José Cabeçadas
- Maria Gomes da Silva
-
P105: Management and Outcomes in Pediatric Nodular Lymphocyte-Predominant Hodgkin Lymphoma: Evidence from a Brazilian Multicenter Cohort
View full abstract at Hemasphere…
- Adriana Morais
- Juliana Costa
- Ana Rosa Costa
- Monica Palese
- Michael Binkley
- Jamie Flerlage
Relapsed and refractory
-
T106: Phase 1 PRIMAVERA Study of the PRMT5 Inhibitor AZD3470 in Patients with Relapsed/Refractory Classic Hodgkin Lymphoma
Abstract Talk in Relapsed & Refractory HL (Monday 10:45–12:15)
View full abstract at Hemasphere…
- Pier Luigi Zinzani
- Franck Morschhauser
- Vincent Ribrag
- Elizabeth H. Phillips
- Herve Ghesquieres
- Hun Ju Lee
- Peter Borchmann
- Paul J. Bröckelmann
- Tae Min Kim
- Katharine Lewis
- Jakub Svoboda
- Antonia Rodriguez Izquierdo
- Won Seog Kim
- Anna Sureda
- Graham P. Collins
- Kaitlyn Beyfuss
- Cedric Dos Santos
- Richard F. Olsson
- Enrico Derenzini
-
T107: Treatment patterns and survival outcomes of patients relapsing after frontline Nivolumab-AVD in advanced stage classical Hodgkin lymphoma (cHL)
Abstract Talk in Relapsed & Refractory HL (Monday 10:45–12:15)
View full abstract at Hemasphere…
- Harsh Shah
- Allison Bock
- Peirong Hao
- Xi Qiao
- Robert Stuver
- Swetha Thiruvengadam
- Azra Borogovac
- Reid Merryman
- Nicole Araujo
- Ayo Falade
- Samin Houshyar
- Daniel Reef
- Gordon Smilnak
- Kanithra Sekaran
- Efrat Luttwak
- Dahlia Sano
- Ajay Major
- Ritwick Mynam
- Grace Baek
- John Sharp
- John Vaughn
- Praveen Ramakrishnan Geethakumari
- Sanjal Desai
- Jessica Allen
- Kelsey Baron
- Tiffany Chang
- Nivetha Ganesan
- Vrutti Patel
- Marisa Palmeri
- Anuja Abhyankar
- Drew Gerber
- Madiha Iqbal
- Hua-Jay Cherng
- Alex Niu
- Joanna Rhodes
- Jakub Svoboda
- Catherine Diefenbach
- Timothy Voorhees
- Mengyang Di
- Priyanka Pophali
- Yasmin Karimi
- Reem Karmali
- Krithika Shanmugasundaram
- Natalie Grover
- Urshila Durani
- Ivana N. Micallef
- Jonathan W. Friedberg
- Tatyana Feldman
- Matthew Mei
- Pallawi Torka
- Philippe Armand
- Alison Moskowitz
- Alex Herrera
- Narendranath Epperla
-
T108: Primary Analysis of the GHSG Pembro-CORE Trial: PET-Adapted PD-1-Based Salvage Therapy Omitting High-Dose Chemotherapy in First-Relapsed Hodgkin Lymphoma
Abstract Talk in Relapsed & Refractory HL (Monday 10:45–12:15)
View full abstract at Hemasphere…
- Hishan Tharmaseelan
- Ina Bühnen
- Helen Kaul
- Sarah Gillessen
- Carsten Kobe
- Karin G. Schrenk
- Philipp Ernst
- Max S. Topp
- Ulf Schnetzke
- Nico Freund
- Stephanie Sasse
- Wolfram Klapper
- Michael Fuchs
- Sven Borchmann
- Paul J. Bröckelmann
- Peter Borchmann
- Bastian von Tresckow
-
P109: Immune Checkpoint Inhibitor Combined with Radiotherapy for Relapsed/Refractory Classical Hodgkin Lymphoma: A Transplant-Free Retrospective Study
View full abstract at Hemasphere…
- Yue Liu
- Jingnan Wang
- Yunpeng Wu
- Xin Liu
- Yongwen Song
- Shu-Nan Qi
- Ye-Xiong Li
-
P110: How to manage BrECADD failure? Early Outcomes of Second-Line Treatment in classic Hodgkin Lymphoma
View full abstract at Hemasphere…
- Christian Peter Jaworek
- Janina Jablonski
- Lisa Marie Sgonina
- Annika Rudat
- Pascal Fichtel
- Thomas Melchardt
- Susanne Ghandili
- Andreas Rank
- Mathias Hänel
- Julia Meissner
- Theresa Halbsguth
- Hishan Tharmaseelan
- Justin Ferdinandus
- Paul J. Bröckelmann
- Peter Borchmann
- Bastian von Tresckow
-
P111: KEYFORM-008: Randomized Phase 2 Study of Coformulated Favezelimab/Pembrolizumab Versus Chemotherapy in Participants With Relapsed or Refractory Classic Hodgkin Lymphoma
View full abstract at Hemasphere…
- Paul J. Bröckelmann
- David Lavie
- Guilherme Perini
- Muhit Ozcan
- Nathalie Johnson
- Won Seog Kim
- Carolina Mahuad
- Norma Gutiérrez
- Senem Maral
- Cecile Borel
- Tae Min Kim
- Iara Goncalves
- Deepa Jagadeesh
- Yasmin Karimi
- Nina Wagner-Johnston
- John Timmerman
- Ryan Lynch
- Graham P. Collins
- Yulia Sidi
- Pallavi Pillai
- Rushdia Yusuf
- Alex Herrera
-
P112: Preliminary Results of Nivolumab and Axatilimab in Patients with Relapsed/Refractory Classical Hodgkin Lymphoma refractory to anti-PD-1 therapy
View full abstract at Hemasphere…
- Harsh Shah
- Dipenkumar Modi
- Kenneth Boucher
- James Marvin
- Jerry Zak
- Anthony Pomicter
- Kelsey Baron
- Daniel Ermann
- Alison Moskowitz
- Radhakrishnan Ramchandren
- Deborah Stephens
- Boyu Hu
-
P113: Eight-year outcomes after nivolumab discontinuation in patients with relapsed/refractory classic Hodgkin lymphoma
View full abstract at Hemasphere…
- Liudmila Fedorova
- Kirill Lepik
- Polina Kotselyabina
- Elena Kondakova
- Andrey Chekalov
- Evgeniya Borzenkova
- Natalia Mikhailova
- Alexander Kulagin
-
P114: Low-Dose Nivolumab Combined with Salvage Chemotherapy in Relapsed/Refractory Classic Hodgkin Lymphoma: Outcomes from a Tertiary Care Centre in North India
View full abstract at Hemasphere…
- Charanpreet Singh
- Aditya Jandial
- Arihant Jain
- Alka Khadwal
- Rajender Basher
- Amanjit Bal
- Gaurav Prakash
- Pankaj Malhotra
-
P115: Outcomes in Double-Exposed Classical Hodgkin Lymphoma: The Impact of Treatment Sequence and Salvage Strategies After Brentuximab Vedotin and Checkpoint Inhibitor Failure
View full abstract at Hemasphere…
- Massimiliano Marinoni
- Tomohiro Aoki
- Sita Bhella
- Inna Gong
- Robert Kridel
- Vishal Kukreti
- Anca Prica
- Abi Vijenthira
- Chloe Yang
- Woodrow Wells
- Danielle Rodin
- David Hodgson
- Michael Crump
- John Kuruvilla
-
P116: PD-1 Inhibitor maintenance after Auto-HCT in r/r Classical Hodgkin lymphoma with prior PD-1 exposure: interim phase II results
View full abstract at Hemasphere…
- Polina Kotselyabina
- Aminat Balaeva
- Liudmila Fedorova
- Vladimir Bogatyrev
- Nikita Shorokhov
- Nikita Mochkin
- Mobil Akhmedov
- Mariya Vernyuk
- Irina Cherkashina
- Azat Karabekov
- Vladislav Sarzhevskiy
- Elena Demina
- Vadim Keimakin
- Natalia Mikhailova
- Alexander Kulagin
-
P117: Association of prior PD-1 inhibitor exposure with pre-engraftment syndrome after ASCT in relapsed/refractory Hodgkin lymphoma
View full abstract at Hemasphere…
- Dávid Tóthfalusi
- Gréta Melani Csatlós
- Boglárka Dobó
- Fanni Borics
- László Imre Pinczés
- Árpád Illés
- Zsófia Miltényi
-
P118: Autologous hematopoietic cell transplantation remains relevant despite PD-1 inhibitor-based second-line therapy in classic Hodgkin lymphoma: interim results from the Prolgo-HL study
View full abstract at Hemasphere…
- Liudmila Fedorova
- Polina Kotselyabina
- Kirill Lepik
- Andrey Chekalov
- Vladislav Markelov
- Valeria Shpirko
- Anastasia Semenova
- Gayane Tumyan
- Stanislav Volchenkov
- Angelina Piletskaya
- Ilya Zyuzgin
- Natalia Konoplya
- Natalia Mikhailova
- Alexander Kulagin
-
P119: Efficacy of Ultra-Low-Dose Nivolumab in Combination with Gemcitabine and Cisplatin as Remission-Induction Therapy in Primary Progressive and Relapsed Hodgkin Lymphoma: A Randomized Phase II study with two ultra-low-dose schedules
View full abstract at Hemasphere…
- Mithun Prakash
- Nutan Joshi
- Sujith Karumathil
- Sushil Selvarajan
- Sharon Lionel
- Uday Kulkarni
- Aby Abraham
- Biju George
- Vikram Mathews
- Anu Korula
-
P120: From Clinical Trials to Clinical Practice: A Decade of Experience with Nivolumab in Relapsed/Refractory Classical Hodgkin Lymphoma
View full abstract at Hemasphere…
- Alice Sykorova
- Jan Koren
- Eva Maule
- Lubica Gaherova
- Marie Lukasova
- Juraj Duras
- Katerina Steinerova
- Pavla Stepankova
- Blanka Vackova
- Jozef Michalka
- Jana Markova
- Vit Prochazka
- Barbara Brizova
- Marek Trneny
- Zdenek Kral
- Petra Blahovcova
- Heidi Mocikova
-
P121: Brentuximab vedotin as bridging and maintenance therapy in hematopoietic cell transplant in a national access program for relapsed or refractory classical Hodgkin lymphoma patients
View full abstract at Hemasphere…
- Omar Fernandez-Vargas
- Maria Silvia Rivas-Vera
- Gladys Agreda-Vásquez
- Ingrid Mucius
- Marco Balandrán-Ruíz
- David Gómez-Almaguer
- Jorge Cruz-Rico
- Perla Colunga-Pedraza
- Carolina Balderas-Delgado
- Carlos Best
- Gabriel Barragán
- Mariela Cardiel
- María Luisa Alcivar
- Sergio Galvez-Acosta
- Rosa Elena Sosa
- Daniela Pérez Karen
- Ana Lucía Ron-Magaña
-
P122: BCL-2 Inhibition Combined with Other Therapeutic Agents Demonstrates Synergistic Efficacy in Hodgkin Lymphoma Cells
View full abstract at Hemasphere…
- Alex Niu
- Noah Brosnick
- Cory Mavis
- Matthew Cortese
- Francisco Hernandez-Ilizaliturri
-
P123: Real-World Data on the Single-Agent Pembrolizumab Therapy in Relapsed / Refractory Classic Hodgkin Lymphoma Patients in the Czech Republic.
View full abstract at Hemasphere…
- Jozef Michalka
- Heidi Móciková
- Katarína Hradská
- Alice Sýkorová
- Vít Procházka
- František Folber
- Eva Maule
- Ľubica Gahérová
- Juraj Ďuraš
- Barbora Obadalová
- Pavla Štěpánková
- Marie Lukášová
- Zdeněk Král
-
P124: Activity of Nivolumab with Decitabine Cedauzurine (DEC-C) in Relapsed/Refractory Hodgkin Lymphoma (cHL): Results from an ETCTN Phase 1 Study
View full abstract at Hemasphere…
- Justin Kline
- Joseph Tuscano
- Guarav Goyal
- Matthew Mei
- Alison Davis
- Geoff Shapiro
- Catherine Diefenbach
-
P125: Three cycles of nivolumab (N) before BGD chemotherapy improves the remission rate before autologous hematopoietic cell transplantation (aHCT) in relapsed/refractory Hodgkin Lymphoma: N-BURGUND trial of the Polish Lymphoma Research Group (PLRG).
View full abstract at Hemasphere…
- Michal Taszner
- Ewa Paszkiewicz-Kozik
- Adam Wyszomirski
- Justyna Rybka
- Karolina Chromik
- Agnieszka Kołkowska-Leśniak
- Edyta Subocz
- Łukasz Targoński
- Paulina Ceklarz
- Magdalena Witkowska
- Ryszard Swoboda
- Katarzyna Domańska-Czyż
- Agnieszka Giza
- Małgorzata Kobylecka
- Conrad-Amadeus Voltin
- Joanna Romejko-Jarosińska
- Beata Ostrowska
- Monika Świerkowska
- Agnieszka Druzd-Sitek
- Michał Kurlapski
- Marta Bednarek
- Bogdan Małkowski
- Grzegorz Romanowicz
- Janusz Hałka
- Tomasz Wróbel
- Sebastian Giebel
- Grzegorz Helbig
- Ewa Lech-Marańda
- Jan Maciej Zaucha
-
P126: REAL WORLD EFFICACY AND SAFETY COMPARISON OF SALVAGE REGIMENS COMBINING BRENTUXIMAB VEDOTIN AND CHEMOTHERAPY IN SECOND-LINE HODGKIN LYMPHOMA: A LYSA MULTICENTER RETROSPECTIVE STUDY.
View full abstract at Hemasphere…
- Juliette Wencel
- Arnaud Pages
- Florian Chevillon
- Robin Noël
- Lucie Laemmel
- Maxime Vignac
- Emilie Corvilain
- Pamela Sfeir
- Milena Kohn
- Guillemette Fouquet
- Maxence Lohez
- Baptsite Delapierre
- Gaétan Basile
- Gaelle Laboure
- Amina Cherait
- Carole Soussain
- Adrien Grenier
- Thorsten Braun
- Laure Ricard
- Axel Andre
- Bénédicte Deau
- Morgane Cheminant
- Jean Galtier
- Pilar Dutari
- Loïc Renaud
-
P127: (Bv)DHAP + G-CSF as an effective peripheral stem cell mobilization regimen in adult patients with relapsed/refractory Hodgkin lymphoma
View full abstract at Hemasphere…
- Maryia Shapetska
- Igar Iskrau
- Marta Valevskaya
- Olga Gerasimovich
- Victoria Smolnikova
-
P128: EHA-4448 REAL-WORLD OUTCOMES OF PEMBROLIZUMAB PLUS GVD AS SALVAGE THERAPY AND BRIDGE TO AUTOLOGOUS STEM CELL TRANSPLANTATION IN RELAPSED/REFRACTORY CLASSICAL HODGKIN LYMPHOMA: A MULTICENTER GATLA STUDY
View full abstract at Hemasphere…
- Astrid Pavlovsky
- Fernando Warley
- Luciano Salvano
- Maria Orlova
- Luciana Guanchiale
- Laura Korin
- Carolina Mahuad
- Jose Ignacio Trucco
- Amalia Cerutti
- Florencia Negri Aranguren
- Guadalupe Antelo Perez
- Bruno Wannesson
- Javier Romano
- Lautaro Sardu
- Veronica Musso
- Etelvina Lucia MacChiavello
- Nadia Scebba
- Trinidad Viviani
- Lorena Fiad
-
P129: You Don't Always Need a Transplant: Checkpoint Inhibitors Can Deliver Lasting Remissions in Relapsed and Refractory Classical Hodgkin Lymphoma
View full abstract at Hemasphere…
- Vivek Radhakrishnan
- Rida Shakeel
- Deedar Singh
- Robert Lown
- Sean Lim
- David Dutton
- Angharad Pryce
- Luke Bennett
- Andrew Bates
- Andrew Davies
- Peter Johnson
-
P130: Second-Generation Epigenetic Clocks Reveal Accelerated Biological Aging in Relapsed/Refractory Hodgkin Lymphoma
View full abstract at Hemasphere…
- Mahek Shah
- Anuja Abhyankar
- Nour Nassour
- Francisco Hernandez-Ilizaliturri
- Joyce Ohm
- Alex Niu
-
P131: Autologous Stem Cell Transplantation after Anti-PD-1 Therapy in Heavily Pretreated Patients with Relapsed/Refractory Classical Hodgkin Lymphoma: Real-World Outcomes
View full abstract at Hemasphere…
- Iuliia Protopopova
- Nikita Mochkin
- Vladislav Sarzhevskiy
- Elena Demina
- Vladimir Melnichenko
- Nikita Shorokhov
- Anastasia Samoylova
- Aisel Mamedova
- Anna Bannikova
- Anatoliy Rukavitsyn
- Elena Smirnova
- Vladimir Bogatyrev
-
P132: Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed/Refractory Classical Hodgkin Lymphoma in the Brentuximab Era: Updated Single-Center Experience
View full abstract at Hemasphere…
- Natalya Milanovich
- Alena Dziuba
- Oksana Marozava
- Yury Strongin
- Oksana Nechay
- Tatsiana Talako
- Natalia Volkovets
- Aliaksandr Avadok
- Anatoly Uss
-
P133: Recurrent Hemophagocytic Lymphohistiocytosis and Hepatic Failure in EBV-Associated Hodgkin Lymphoma
View full abstract at Hemasphere…
- Ignacio Tobarra
- Marc Bosch
- M Laura Fox
- Josep Castellví
- Cristina García
- Pau Abrisqueta
- Cecilia Carpio
- Jhon Kevin Fuentes
-
P134: IMPACT OF PRE-TRANSPLANT BRENTUXIMAB VEDOTIN ON TOXICITIES AND OUTCOMES OF AUTOLOGOUS STEM CELL TRANSPLANTATION IN PATIENTS WITH RELAPSED/REFRACTORY HODGKIN LYMPHOMA
View full abstract at Hemasphere…
- Clara Sanches
- Miguel Neto
- Filipa Osório
- Ana Isabel Brito
- Margarida Badior
- Inês Carvalhais
- Ana Carneiro
- Pedro Medeiros
- Filipa Moita
- Ana Luísa Pinto
- Ricardo Pinto
- Fernanda Trigo
-
P135: Immunophenotyping of CD8+ T cells from classical Hodgkin Lymphoma patients treated with PD-1 blockade
View full abstract at Hemasphere…
- Matthew Salaciak
- Tho-Alfakar Al-Aubodah
- Samantha Worme
- Laura Widawski
- Claudia L. Kleinman
- Ioannis Ragoussis
- Ryan Rys
- Madelyn Abraham
- Angelo Rizzolo
- Paige McCallum
- Christophe Goncalves
- Gerben Duns
- Christian Steidl
- Sonia Del Rincon
- Koren K. Mann
- Ciriaco Piccirillo
- Francois E. Mercier
- Nathalie Johnson
-
P136: Post-ASCT Brentuximab Vedotin (BV) maintenance in high-risk relapsed/refractory Hodgkin lymphoma in the era of novel salvage therapies: a bias-adjusted analysis of 4 LYSA real-world cohorts.
View full abstract at Hemasphere…
- Amira Marouf
- Tesla Murari Mirimo
- Jean Galtier
- Gaétan Basile
- Pilar Dutari
- Cédric Rossi
- Fanny Cherblanc
- Loïc Chartier
- Krimo Bouabdallah
- Robin Noel
- Hervé Ghesquières
- Bénédicte Deau-Fischer
-
P137: Anti PD1 containing salvage regimen is highly effective in chemorefractory HL patients
View full abstract at Hemasphere…
- Francesca Pierdomenico Maciel
- Carolina Freitas
- Diana Viegas
- Inês Coelho
- Maria Inês Barbosa
- Alina Ionita
- Susana Carvalho
- Maria Gomes da Silva
Resource constrained setting
-
P139: Implementation of BrECADD According to HD21 Standards in a Middle-Income Country: Barriers and Feasibility in Mexican Public Hospitals
View full abstract at Hemasphere…
- Laura Nayeli Tecayehuatl Negrete
- Luis Felipe Rubalcava Lara
- Gerardo Santiago Jiménez
- Alonso Hernández Company
- Perla Rocío Colunga Pedraza
- Bogar Pineda Terreros
- Martín Jacobo Pacheco
- María Eugenia Mejía Chávez
- Karina Angelica Arzate Ramírez
- María Catalina López Aparicio
- Ramón Alberto Barreda González
- Ana Xochitl Muñoz Gutierrez
- Juan Rangel Patiño
Categories
Award Winners
Karl Musshoff Prize: Best Clinical Abstract
Judith Trotmann
T093: The MyHodgkin MyHealth App: patient-derived data for tracking Hodgkin Lymphoma survivorship
Karl Musshoff Prize: Best Preclinical Abstract
Wolfram Klapper
T047: Artificial intelligence predicts EBV status and reveals prognostic morphology phenotypes in advanced-stage classic Hodgkin lymphoma
Abstract Award
